Role of apathy in the effectiveness of weight management programmes

Diabetes, Obesity and Metabolism

Volumn 14, Issue 5, 2012, Pages 419-423

  Desouza, C V ^a,b   Padala, P R ^c,d   Haynatzki, G ^b   Anzures, P ^a   Demasi, C ^a   Shivaswamy, V ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Obesity therapy; Randomized trial; Weight loss therapy

Indexed keywords

METHYLPHENIDATE;

ADULT; APATHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUNSELING; GOVERNMENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NUTRITION; OBESITY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT REDUCTION;

EID: 84859441898     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01544.x     Document Type: Article

References (22)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
2. Nelson KM. The burden of obesity among a national probability sample of veterans. J Gen Intern Med 2006; 21: 915-919.
3. Wang A, Kinsinger LS, Kahwati LC et al. Obesity and weight control practices in 2000 among veterans using VA facilities. Obes Res 2005; 13: 1405-1411.
4. Aggoun Y. Obesity, metabolic syndrome, and cardiovascular disease. Pediatr Res 2007; 61: 653-659.
5. Grimm W, Becker HF. Obesity, sleep apnea syndrome, and rhythmogenic risk. Herz 2006; 31: 213-218.
6. Byrne NM, Meerkin JD, Laukkanen R, Ross R, Fogelholm M, Hills AP. Weight loss strategies for obese adults: personalized weight management program vs. standard care. Obesity (Silver Spring) 2006; 14: 1777-1788.
7. Carels RA, Darby L, Cacciapaglia HM et al. Using motivational interviewing as a supplement to obesity treatment: a stepped-care approach. Health Psychol 2007; 26: 369-374.
8. Delinsky SS, Latner JD, Wilson GT. Binge eating and weight loss in a self-help behavior modification program. Obesity (Silver Spring) 2006; 14: 1244-1249.
9. Greenberg I, Perna F, Kaplan M, Sullivan MA. Behavioral and psychological factors in the assessment and treatment of obesity surgery patients. Obes Res 2005; 13: 244-249.
10. Kalarchian MA, Marcus MD, Levine MD et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005; 66: 1058-1063.
11. Linde JA, Jeffery RW, French SA, Pronk NP, Boyle RG. Self-weighing in weight gain prevention and weight loss trials. Ann Behav Med 2005; 30: 210-216.
12. Grubbs L. Winning the battle of the bulge. Practical approaches to weight loss. Adv Nurse Pract 2009; 17: 33-34, 36-38.
13. Kloiber S, Ising M, Reppermund S et al. Overweight and obesity affect treatment response in major depression. Biol Psychiatry 2007; 62: 321-326.
14. Kim JY, Oh DJ, Yoon TY, Choi JM, Choe BK. The impacts of obesity on psychological well-being: a cross-sectional study about depressive mood and quality of life. J Prev Med Pub Health 2007; 40: 191-195.
15. van Reekum R, Stuss DT, Ostrander L. Apathy: why care? J Neuropsychiatry Clin Neurosci 2005; 17: 7-19.
16. Robert PH, Berr C, Volteau M et al. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clin Neurol Neurosurg 2006; 108: 733-736.
17. Richard IH. Apathy does not equal depression in Parkinson disease: why we should care. Neurology 2006; 67: 10-11.
18. Padala PR, Petty F, Bhatia SC. Methylphenidate may treat apathy independent of depression. Ann Pharmacother 2005; 39: 1947-1949.
19. Glenn MB, Burke DT, O'Neil-Pirozzi T, Goldstein R, Jacob L, Kettell J. Cutoff score on the apathy evaluation scale in subjects with traumatic brain injury. Brain Inj 2002; 16: 509-516.
20. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res 1991; 38: 143-162.
21. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004; 39(4 Pt 1): 1005-1026.
22. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res 2005; 40(6 Pt 1): 1918-1930.